Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 3:09 am
Author: Getaka|Social: XLinkedIn

JHS Svendgaard Laboratories Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹26.83Undervalued by 271.09%vs CMP ₹7.23

P/E (15.0) × ROE (10.8%) × BV (₹20.30) × DY (2.00%)

Defaults: P/E=15

₹15.55Undervalued by 115.08%vs CMP ₹7.23
MoS: +53.5% (Strong)Confidence: 40/100 (Low)Models: 3 Under, 2 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹26.8334%Under (+271.1%)
Net Asset ValueAssets₹19.8620%Under (+174.7%)
EV/EBITDAEnterprise₹3.3017%Over (-54.4%)
ROCE CapitalReturns₹1.8814%Over (-74%)
Revenue MultipleRevenue₹10.5215%Under (+45.5%)
Consensus (5 models)₹15.55100%Undervalued
Key Drivers: Wide model spread (₹2–₹27) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 0.0% · Defaults: P/E=15

*Investments are subject to market risks

Investment Snapshot

57
JHS Svendgaard Laboratories Ltd scores 57/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health45/100 · Moderate
ROCE 5.2% WeakROE 10.8% AverageD/E 0.00 Low debtInterest Coverage 0.0x RiskyProfitable 1/5 years Inconsistent
Smart Money70/100 · Strong
FII holding up 2.01% (6mo) AccumulatingPromoter holding at 33.9% Stable
Earnings Quality75/100 · Strong
OPM expanding (-6% → -3%) ImprovingWorking capital: 48 days (improving) Efficient
Quarterly Momentum70/100 · Strong
Revenue (4Q): +6% YoY GrowingOPM: 7.2% (up 6.1% YoY) Margin expansion
Industry Rank25/100 · Weak
ROCE 5.2% vs industry 29.2% Below peersROE 10.8% vs industry 23.9% Below peers3Y sales CAGR: 2% Slow

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

JHS Svendgaard Laboratories Ltd Investor Signals

Computed from valuation, cash flow, balance sheet, ownership and quarterly trend data already available in this stock page.

Value Trap Score
40/100
Moderate
Derived from: Cheapness + weak quality + weak cash support
Current data: P/E 0.0 vs Ind 46.9 | ROCE 5.2% | ROE 10.8% | CFO/NP N/A
Balance Sheet Stress
20/100
Comfortable
Derived from: Leverage + debt servicing + liquidity + debt trend
Current data: D/E 0.00x | IntCov 0.0x | Current 5.23x | Borrow/Reserve 0.12x
Cash Flow Reliability
86/100
Strong
Derived from: Cash backing of earnings + working capital pressure
Current data: CFO ₹0 Cr | NP ₹-20 Cr | CFO/NP N/A
Ownership Accumulation
0
Neutral
Derived from: FII + DII + promoter direction, adjusted by crowding
Current data: FII +2.03 pp | DII 0.00 pp | Prom -0.71 pp
Business Momentum
+17
Stable
Derived from: Latest quarter sales + profit + OPM change
Current data: Q Sales +4.4% | Q NP +495.0% | Q OPM +3.1 pp
Derived FieldValueHow it is derived
Valuation Gap %+115.1%((Fair Value - CMP) / CMP) × 100
Borrowings / Reserves0.12xLatest borrowings divided by latest reserves
CFO / Net ProfitN/ALatest operating cash flow divided by latest net profit
FII Change+2.03 ppLatest FII% minus previous FII%
DII Change0.00 ppLatest DII% minus previous DII%
Promoter Change-0.71 ppLatest promoter% minus previous promoter%
Shareholder Count Change+226Latest shareholder count minus previous count
Quarterly Sales Change+4.4%Latest quarter sales vs previous quarter sales
Quarterly Profit Change+495.0%Latest quarter net profit vs previous quarter net profit
Quarterly OPM Change+3.1 ppLatest quarter OPM minus previous quarter OPM

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 3:09 am

Market Cap 63.2 Cr.
Current Price 7.23
Intrinsic Value₹15.55
High / Low 16.5/6.15
Stock P/E
Book Value 20.3
Dividend Yield0.00 %
ROCE5.19 %
ROE10.8 %
Face Value 10.0
PEG Ratio0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for JHS Svendgaard Laboratories Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Honasa Consumer Ltd 10,003 Cr. 307 334/19064.7 38.80.00 %7.44 %5.51 % 10.0
Ambica Agarbathies Aroma & Industries Ltd 38.0 Cr. 22.2 33.0/20.055.1 65.20.00 %7.49 %0.45 % 10.0
Ador Multi Products Ltd 119 Cr. 105 149/60.0 32.50.00 %11.4 %3.09 % 10.0
Kaya Ltd 379 Cr. 249 488/204 60.90.00 %2.50 %% 10.0
Jyothy Labs Ltd 7,551 Cr. 206 400/19620.6 55.81.70 %24.6 %19.0 % 1.00
Industry Average60,427.93 Cr1,572.1446.89111.991.02%29.21%23.91%4.94

All Competitor Stocks of JHS Svendgaard Laboratories Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 22.1921.7215.9018.9314.3021.6624.4819.6822.6625.1723.4522.2823.27
Expenses 24.4125.2818.0218.5214.3620.8222.5120.5222.4130.5521.7921.3721.60
Operating Profit -2.22-3.56-2.120.41-0.060.841.97-0.840.25-5.381.660.911.67
OPM % -10.00%-16.39%-13.33%2.17%-0.42%3.88%8.05%-4.27%1.10%-21.37%7.08%4.08%7.18%
Other Income 0.94-11.540.410.202.341.370.320.860.27-1.441.001.140.59
Interest 0.160.110.130.100.110.130.120.110.130.210.160.200.28
Depreciation 1.461.611.321.501.631.901.971.981.972.021.881.861.90
Profit before tax -2.90-16.82-3.16-0.990.540.180.20-2.07-1.58-9.050.62-0.010.08
Tax % -4.83%-36.39%-18.35%-26.26%100.00%516.67%415.00%398.07%15.82%-23.09%-69.35%1,800.00%-887.50%
Net Profit -2.76-10.71-2.59-0.730.01-0.75-0.63-10.32-1.84-6.961.06-0.200.79
EPS in Rs -0.43-1.65-0.40-0.090.00-0.10-0.08-1.21-0.21-0.810.12-0.020.09

Last Updated: March 4, 2026, 7:16 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 24, 2026, 4:16 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 35.2855.1099.62104.18140.29123.99139.11100.7786.2584.8170.8092.0094.17
Expenses 39.0658.9593.1192.45126.34123.89137.4098.8087.0993.8871.7396.0195.31
Operating Profit -3.78-3.856.5111.7313.950.101.711.97-0.84-9.07-0.93-4.01-1.14
OPM % -10.71%-6.99%6.53%11.26%9.94%0.08%1.23%1.95%-0.97%-10.69%-1.31%-4.36%-1.21%
Other Income -2.67-5.79-17.300.3932.035.973.167.499.39-7.314.310.021.29
Interest 14.140.140.360.620.741.031.951.241.390.550.460.570.85
Depreciation 14.7112.3610.496.366.817.098.767.257.056.026.357.957.66
Profit before tax -35.30-22.14-21.645.1438.43-2.05-5.840.970.11-22.95-3.43-12.51-8.36
Tax % -18.39%0.18%0.00%-326.85%32.19%-18.54%-16.95%-39.18%4,000.00%-23.66%18.37%57.87%
Net Profit -28.81-22.18-21.6421.9426.06-1.67-4.861.34-4.29-17.52-4.06-19.74-5.31
EPS in Rs -11.95-9.20-5.764.984.29-0.11-0.330.19-0.620.62-0.52-2.31-0.62
Dividend Payout % 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)23.01%2.43%201.39%18.78%-106.41%-191.02%127.57%-420.15%-308.39%76.83%-386.21%
Change in YoY Net Profit Growth (%)0.00%-20.58%198.95%-182.61%-125.19%-84.61%318.59%-547.72%111.76%385.22%-463.03%

JHS Svendgaard Laboratories Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:5%
5 Years:-8%
3 Years:2%
TTM:15%
Compounded Profit Growth
10 Years:-2%
5 Years:%
3 Years:%
TTM:-624%
Stock Price CAGR
10 Years:0%
5 Years:-9%
3 Years:-23%
1 Year:-61%
Return on Equity
10 Years:2%
5 Years:0%
3 Years:0%
Last Year:-11%

Last Updated: September 5, 2025, 8:15 am

Balance Sheet

Last Updated: December 10, 2025, 2:54 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 24.1024.1037.6444.1260.9060.9060.9064.4064.9078.4078.4085.6085.60
Reserves 38.0195.5062.9590.25113.36115.94117.10124.30121.0095.4491.4987.1288.04
Borrowings 54.1218.822.562.312.497.198.587.016.192.585.136.4610.59
Other Liabilities 74.1932.9319.2618.5731.5938.5454.8832.7230.0151.8122.0424.6222.67
Total Liabilities 190.42171.35122.41155.25208.34222.57241.46228.43222.10228.23197.06203.80206.90
Fixed Assets 120.88107.8965.1065.0071.4170.8165.6363.2258.5265.0790.4190.3388.32
CWIP 0.030.030.680.670.514.807.058.9219.968.570.820.002.95
Investments 0.000.000.001.0318.199.756.032.053.622.973.453.644.88
Other Assets 69.5163.4356.6388.55118.23137.21162.75154.24140.00151.62102.38109.83110.75
Total Assets 190.42171.35122.41155.25208.34222.57241.46228.43222.10228.23197.06203.80206.90

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 28.177.29-3.77-3.9313.80-10.7910.3512.03-9.1423.29-9.18-5.18
Cash from Investing Activity + 2.741.321.48-3.36-27.02-6.87-10.97-2.23-4.709.68-21.14-20.25
Cash from Financing Activity + -29.14-9.754.2110.1113.6312.530.4910.31-1.67-0.642.1723.07
Net Cash Flow 1.77-1.131.922.830.42-5.13-0.1320.11-15.5032.33-28.14-2.36
Free Cash Flow 30.648.53-6.59-16.643.42-26.370.115.43-15.5420.71-32.91-14.43
CFO/OP -748%-189%-58%-33%119%-10,000%595%650%1,051%-257%1,001%122%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-57.90-22.673.959.4211.46-7.09-6.87-5.04-7.03-11.65-6.06-10.47

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 188167254811115825221377806652
Inventory Days 12294539565603097114128176153
Days Payable 9510667123153134177128130197197141
Cash Conversion Cycle 2151561219238510518261114663
Working Capital Days -708-395856122173198272217415148
ROCE %-10%-12%-3%5%8%-0%4%1%1%-2%-2%-5%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Feb 2026
Promoters 42.23%37.73%37.73%37.73%37.73%34.56%34.56%34.56%34.56%34.56%34.56%33.85%
FIIs 0.00%0.00%0.00%2.29%0.15%1.69%1.59%1.60%1.59%1.57%1.57%3.60%
DIIs 0.00%0.00%9.16%6.21%6.05%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Public 57.78%62.25%53.10%53.75%56.05%63.76%63.85%63.84%63.86%63.87%63.86%62.56%
No. of Shareholders 23,80022,79422,64826,44825,76825,99426,27625,56725,15525,00725,15125,377

Shareholding Pattern Chart

No. of Shareholders

JHS Svendgaard Laboratories Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) -2.37-0.52-2.34-0.630.20
Diluted EPS (Rs.) -2.37-0.52-2.34-0.630.20
Cash EPS (Rs.) -1.380.29-1.430.421.33
Book Value[Excl.RevalReserv]/Share (Rs.) 20.1821.6727.7830.0530.74
Book Value[Incl.RevalReserv]/Share (Rs.) 20.1821.6727.7830.0530.74
Revenue From Operations / Share (Rs.) 10.759.0314.8213.2915.65
PBDIT / Share (Rs.) -0.130.430.811.321.47
PBIT / Share (Rs.) -1.06-0.37-0.330.230.34
PBT / Share (Rs.) -1.46-0.43-3.370.010.15
Net Profit / Share (Rs.) -2.31-0.51-2.58-0.660.20
NP After MI And SOA / Share (Rs.) -2.31-0.51-2.38-0.620.18
PBDIT Margin (%) -1.234.775.509.919.39
PBIT Margin (%) -9.87-4.19-2.251.732.19
PBT Margin (%) -13.59-4.84-22.700.110.96
Net Profit Margin (%) -21.46-5.73-17.43-4.971.33
NP After MI And SOA Margin (%) -21.46-5.73-16.07-4.691.18
Return on Networth / Equity (%) -11.43-2.38-8.96-2.170.63
Return on Capital Employeed (%) -5.14-1.70-1.090.731.07
Return On Assets (%) -9.81-2.05-6.54-1.820.52
Total Debt / Equity (X) 0.020.020.000.000.00
Asset Turnover Ratio (%) 0.460.320.410.360.42
Current Ratio (X) 2.181.872.364.185.23
Quick Ratio (X) 1.701.332.003.544.73
Inventory Turnover Ratio (X) 7.503.114.365.168.94
Interest Coverage Ratio (X) -2.017.345.096.137.63
Interest Coverage Ratio (Post Tax) (X) -28.88-7.822.78-2.082.08
Enterprise Value (Cr.) 81.22121.6970.51136.74117.07
EV / Net Operating Revenue (X) 0.881.720.731.591.16
EV / EBITDA (X) -71.6836.0313.3115.9912.37
MarketCap / Net Operating Revenue (X) 1.041.811.061.551.27
Price / BV (X) 0.550.750.590.710.68
Price / Net Operating Revenue (X) 1.041.811.061.551.27
EarningsYield -0.20-0.03-0.15-0.030.01

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

JHS Svendgaard Laboratories Ltd. is a Public Limited Listed company incorporated on 08/10/2004 and has its registered office in the State of Himachal Pradesh, India. Company's Corporate Identification Number(CIN) is L74110HP2004PLC027558 and registration number is 027558. Currently company belongs to the Industry of Personal Care. Company's Total Operating Revenue is Rs. 92.00 Cr. and Equity Capital is Rs. 85.60 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Personal CareTrilokpur Road, Kheri (Kala Amb), Sirmour Dist. Himachal Pradesh 173030Contact not found
Management
NamePosition Held
Mr. Rajagopal Chakravarthi VenkateishChairman & Ind.Director
Mr. Nikhil NandaManaging & Executive Director
Mr. Vinay MittalNon Executive Director
Mr. Kapil MinochaIndependent Director
Mrs. Upma ChawdhryIndependent Woman Director

FAQ

What is the intrinsic value of JHS Svendgaard Laboratories Ltd and is it undervalued?

As of 05 April 2026, JHS Svendgaard Laboratories Ltd's intrinsic value is ₹15.55, which is 115.08% higher than the current market price of ₹7.23, suggesting the stock is undervalued. This is calculated using the PE ratio method factoring in ROE (10.8 %), book value (₹20.3), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of JHS Svendgaard Laboratories Ltd?

JHS Svendgaard Laboratories Ltd is trading at ₹7.23 as of 05 April 2026, with a FY2026-2027 high of ₹16.5 and low of ₹6.15. The stock is currently near its 52-week low. Market cap stands at ₹63.2 Cr..

How does JHS Svendgaard Laboratories Ltd's P/E ratio compare to its industry?

JHS Svendgaard Laboratories Ltd has a P/E ratio of , which is below the industry average of 46.89. This is broadly in line with or below the industry average.

Is JHS Svendgaard Laboratories Ltd financially healthy?

Key indicators for JHS Svendgaard Laboratories Ltd: ROCE of 5.19 % is on the lower side compared to the industry average of 29.21%. Dividend yield is 0.00 %.

Is JHS Svendgaard Laboratories Ltd profitable and how is the profit trend?

JHS Svendgaard Laboratories Ltd reported a net profit of ₹-20 Cr in Mar 2025 on revenue of ₹92 Cr. Compared to ₹-4 Cr in Mar 2022, the net profit shows a mixed trend.

Does JHS Svendgaard Laboratories Ltd pay dividends?

JHS Svendgaard Laboratories Ltd has a dividend yield of 0.00 % at the current price of ₹7.23. The company is currently not paying meaningful dividends.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in JHS Svendgaard Laboratories Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports